Pharmaplast spending EGP 40 mn to new plant first phase in Alexandria

Pharmaplast began work on the EGP 40 mn first phase of a new production facility in the Alexandria public free zone, Al Borsa said on Wednesday. The new plant will manufacture meds and equipment for the treatments of wounds and burns, according to CEO Mamdouh Attiya. The project will come online in mid-2018 and expects to make around EGP 100 mn a year. Pharmaplast has more investment plans in the pipeline.